These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 11299782)
1. Apoptosis-induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment. Zalatnai A; Pogány V Anticancer Res; 2001; 21(1A):477-80. PubMed ID: 11299782 [TBL] [Abstract][Full Text] [Related]
2. Short-term octreotide treatment induces apoptosis in human pancreatic cancer xenografts. Zalatnai A; Bocsi J In Vivo; 2006; 20(4):549-52. PubMed ID: 16900788 [TBL] [Abstract][Full Text] [Related]
3. Flow cytometric evidence of apoptosis in human pancreatic cancer xenografts treated with Sandostatin (octreotide). Zalatnai A; Szegedi Z; Bocsi J Anticancer Res; 2000; 20(3A):1663-6. PubMed ID: 10928088 [TBL] [Abstract][Full Text] [Related]
4. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation. Abe M; Yamashita J; Ogawa M Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710 [TBL] [Abstract][Full Text] [Related]
5. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice. Weckbecker G; Raulf F; Bodmer D; Bruns C Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482 [TBL] [Abstract][Full Text] [Related]
6. Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts. Zalatnai A; Bocsi J Anticancer Res; 2003; 23(5A):4007-9. PubMed ID: 14666710 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo]. Wang C; Tang C; Tang L Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709 [TBL] [Abstract][Full Text] [Related]
8. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer. Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide]. Wang CH; Tang CW Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891 [TBL] [Abstract][Full Text] [Related]
10. Effect of SILA-409, a new organosilicon multidrug resistance modifier, on human pancreatic cancer xenografts. Zalatnai A; Molnár J In Vivo; 2006; 20(1):137-40. PubMed ID: 16433042 [TBL] [Abstract][Full Text] [Related]
11. Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: a possible anti-tumour mechanism. Xidakis C; Kolios G; Valatas V; Notas G; Mouzas I; Kouroumalis E Anticancer Res; 2004; 24(2B):833-41. PubMed ID: 15161035 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related]
13. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins. Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301 [TBL] [Abstract][Full Text] [Related]
14. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Itashiki Y; Harada K; Ferdous T; Yoshida H Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527 [TBL] [Abstract][Full Text] [Related]
15. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513 [TBL] [Abstract][Full Text] [Related]
16. Antineoplastic mechanism of Octreotide action in human hepatoma. Chen X; Liu Z; Ai Z Chin Med J (Engl); 2001 Nov; 114(11):1167-70. PubMed ID: 11729512 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth. Chen J; Ouyang ZG; Zhang SH; Zhen YS Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403 [TBL] [Abstract][Full Text] [Related]
18. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373 [TBL] [Abstract][Full Text] [Related]
19. Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer. Mełen-Mucha G; Winczyk K; Pawlikowski M Anticancer Res; 1998; 18(5A):3615-9. PubMed ID: 9858948 [TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]